Please assess the completion status of the following clinical trial:

Trial Title: Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Community-dwelling patients ≥ 18 years of age with incurable,histologically diagnosed cancer.~* Involuntary loss of body weight of ≥ 5 % within the past 6 months~Exclusion Criteria:~* Presently hospitalized or in a nursing care facility.~* Inability to increase food intake from secondary causes.~* Liver disease~* If female-pregnant, breast-feeding or of childbearing potential.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- RC-1291 HCl (Type: ACTIVE_COMPARATOR): 50 mg
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).